The role of connexin-mediated cell-cell communication in breast cancer metastasis

Journal of Mammary Gland Biology and Neoplasia

Volumn 6, Issue 4, 2001, Pages 431-440

  Carystinos, George D ^a   Bier, Andrew ^a   Batist, Gerald ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Breast; Connexin; Gap junction; Metastasis

Indexed keywords

ANGIOPOIETIN; APC PROTEIN; BATIMASTAT; CAROTENOID; CELL ADHESION MOLECULE; CONNEXIN 26; CONNEXIN 30; CONNEXIN 32; CONNEXIN 37; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; CYCLIC AMP; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FIBROBLAST GROWTH FACTOR; GAP JUNCTION PROTEIN; K RAS PROTEIN; MATRIX METALLOPROTEINASE; NERVE CELL ADHESION MOLECULE; PROTEIN TYROSINE KINASE; PROTEIN ZO1; RETINOID; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; UVOMORULIN; VASCULOTROPIN;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL COMMUNICATION; CELL CYCLE; CELL DIFFERENTIATION; CELL HETEROGENEITY; CORRELATION FUNCTION; ENZYME INHIBITION; GAP JUNCTION; HUMAN; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL JUNCTION; FEMALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BREAST NEOPLASMS; CELL COMMUNICATION; CONNEXINS; FEMALE; GAP JUNCTIONS; HUMANS; NEOPLASM METASTASIS;

EID: 0035496523     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014787014851     Document Type: Review

References (72)

1. J. W. Holder, E. Elmore, and J. C. Barrett (1993). Gap junction function and cancer. Cancer Res. 53:3475-3485.
2. J. E. Trosko and R. J. Ruch (1998). Cell-cell communication in carcinogenesis. Front Biosci. 3:D208-D236. (Process Citation)
3. D. A. Goodenough, J. A. Goliger, and D. L. Paul (1996). Connexins, connexons, and intercellular communication. Annu. Rev. Biochem. 65:475-502.
4. M. Zhang and S. S. Thorgeirsson (1994). Modulation of connexins during differentiation of oval cells into hepatocytes. Exp. Cell Res. 213:37-42.
5. P. Monaghan and D. Moss (1996). Connexin expression and gap junctions in the mammary gland. Cell Biol. Int. 20:121-125.
6. A. Pozzi, B. Risek, D. T. Kiang, N. B. Gilula, and N. M. Kumar (1995). Analysis of multiple gap junction gene products in the rodent and human mammary gland. Exp. Cell Res. 220:212-219.
7. S. Jamieson, J. J. Going, R. D'Arcy, and W. D. George (1998). Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J. Pathol. 184:37-43.
8. D. Locke (1998). Gap junctions in normal and neoplastic mammary gland. J. Pathol. 186:343-349.
9. P. Monaghan, C. Clarke, N. P. Perusinghe, D. W. Moss, X. Y. Chen, and W. H. Evans (1996). Gap junction distribution and connexin expression in human breast. Exp. Cell Res. 223:29-38.
10. E. C. Beyer, D. L. Paul, and D. A. Goodenough (1987). Connexin43: A protein from rat heart homologous to a gap junction protein from liver. J. Cell Biol. 105:2621-2629.
11. A. G. Reaume, P. A. de Sousa, S. Kulkarni, B. L. Langille, D. Zhu, T. C. Davies, S. C. Juneja, G. M. Kidder, and J. Rossant (1995). Cardiac malformation in neonatal mice lacking connexin43. Science 267: 831-1834. (comments)
12. G. I. Fishman, R. L. Eddy, T. B. Shows, L. Rosenthal, and L. A. Leinwand (1991). The human connexin gene family of gap junction proteins: Distinct chromosomal locations but similar structures. Genomics 10:250-256.
13. T. Toyofuku, M. Yabuki, K. Otsu, T. Kuzuya, M. Hori, and M. Tada (1998). Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes. J. Biol. Chem. 273:12725-12731.
14. H. Yamasaki, M. Mesnil, Y. Omori, N. Mironov, and V. Krutovskikh (1995). Intercellular communication and carcinogenesis. Mutat. Res. 333:181-188.
15. M. M. Atkinson, P. D. Lampe, H. H. Lin, R. Kollander, X. R. Li, and D. T. Kiang (1995). Cyclic AMP modifies the cellular distribution of connexin43 and induces a persistent increase in the junctional permeability of mouse mammary tumor cells. J. Cell Sci. 108: 079-3090.
16. H. Guo, P. Acevedo, F. D. Parsa, and J. S. Bertram (1992). Gap-junctional protein connexin 43 is expressed in dermis and epidermis of human skin: Differential modulation by retinoids. J. Invest. Dermatol. 99:460-467.
17. J. S. Bertram (1999). Carotenoids and gene regulation. Nutr Rev. 57:182-191.
18. Y. S. Jou, B. Layhe, D. F. Matesic, C. C. Chang, A. W. de Feijter, L. Lockwood, C. W. Welsch, J. E. Klaunig, and J. E. Trosko (1995). Inhibition of gap junctional intercellular communication and malignant transformation of rat liver epithelial cells by neu oncogene. Carcinogenesis 16:311-317.
19. A. Hofer, J. C. Saez, C. C. Chang, J. E. Trosko, D. C. Spray, and R. Dermietzel (1996). C-erbB2/neu transfection induces gap junctional communication incompetence in glial cells. J. Neurosci. 16: 311-4321.
20. M. Y. Kanemitsu, L. W. Loo, S. Simon, A. F. Lau, and W. Eckhart (1997). Tyrosine phosphorylation of connexin 43 by v-Src is mediated by SH2 and SH3 domain interactions. J. Biol. Chem. 272:22824-22831.
21. L. W. Loo, J. M. Berestecky, M. Y. Kanemitsu, and A. F. Lau (1995). pp60src-mediated phosphorylation of connexin 43, a gap junction protein. J. Biol. Chem. 270:12751-12761.
22. A. W. de Feijter, D. F. Matesic, R. J. Ruch, X. Guan, C. C. Chang, and J. E. Trosko (1996). Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol. Carcin. 16:203-212.
23. D. W. Laird, P. Fistouris, G. Batist, L. Alpert, H. T. Huynh, G. D. Carystinos, and M. A. Alaoui-Jamali (1999). Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res. 59:4104-4110.
24. L. S. Musil, B. A. Cunningham, G. M. Edelman, and D. A. Goodenough (1990). Differential phosphorylation of the gap junction protein connexin43 in junctional communication-competent and -deficient cell lines. J. Cell Biol. 111:2077-2088.
25. W. M. Jongen, D. J. Fitzgerald, M. Asamoto, C. Piccoli, T. J. Slaga, D. Gros, M. Takeichi, and H. Yamasaki (1991). Regulation of connexin 43-mediated gap junctional intercellular communication by Ca2+ in mouse epidermal cells is controlled by E-cadherin. J. Cell Biol. 114:545-555.
26. R. A. Meyer, D. W. Laird, J. P. Revel, and R. G. Johnson (1992). Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J. Cell Biol. 119:179-189.
27. M. Hsu, T. Andl, G. Li, J. L. Meinkoth, and M. Herlyn (2000). Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J. Cell Sci. 113:1535-1542.
28. M. A. van der Heyden, M. B. Rook, M. M. Hermans, G. Rijksen, J. Boonstra, L. H. Defize, and O. H. Destree (1998). Identification of connexin43 as a functional target for Wnt signalling. J. Cell Sci. 111: 741-1749.
29. L. Koffler, S. Roshong, P. Kyu, I. K. Cesen-Cummings, D. C. Thompson, L. D. Dwyer-Nield, P. Rice, C. Mamay, A. M. Malkinson, and R. J. Ruch (2000). Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1) after forced connexin expression in lung and liver carcinoma cells. J. Cell Biochem. 79:347-354. (Process Citation)
30. S. C. Chen, D. B. Pelletier, P. Ao, and A. L. Boynton (1995). Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ. 6:681-690.
31. D. B. Gros and H. J. Jongsma (1996). Connexins in mammalian heart function. Bioessays 18:719-730.
32. R. Dermietzel and D. C. Spray (1993). Gap junctions in the brain: Where, what type, how many and why? Trends Neurosci. 16: 86-192.
33. H. J. Donahue, Z. Li, Z. Zhou, and C. E. Yellowley (2000). Differentiation of human fetal osteoblastic cells and gap junctional intercellular communication. Am. J. Physiol Cell Physiol 278: 315-C322.
34. W. R. Lowenstein and Y. Kanno (1966). Intercellular communication and the control of tissue growth: Lack of communication between cancer cells. Nature 209:1248-1249.
35. I. S. Fentiman (1980). Cell communication in breast cancer. Ann. R. Coll. Surg. Engl. 62:280-286.
36. W. R. Loewenstein (1979). Junctional intercellular communication and the control of growth. Biochim. Biophys. Acta 560:1-65.
37. V. Krutovskikh, G. Mazzoleni, N. Mironov, Y. Omori, A. M. Aguelon, M. Mesnil, F. Berger, C. Partensky, and H. Yamasaki (1994). Altered homologous and heterologous gap-junctional intercellular communication in primary human liver tumors associated with aberrant protein localization but not gene mutation of connexin 32. Int. J. Cancer 56: 7-94.
38. I. V. Budunova and G. M. Williams (1994). Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication. Cell Biol. Toxicol. 10:71-116.
39. H. S. Rosenkranz, N. Pollack, and A. R. Cunningham (2000). Exploring the relationship between the inhibition of gap junctional intercellular communication and other biological phenomena. Carcinogenesis 21: 007-1011.
40. M. Rosenkranz, H. S. Rosenkranz, and G. Klopman (1997). Intercellular communication, tumor promotion and non-genotoxic carcinogenesis: Relationships based upon structural considerations. Mutat. Res. 381:171-188.
41. V. A. Krutovskikh, M. Oyamada, and H. Yamasaki (1991). Sequential changes of gap-junctional intercellular communications during multistage rat liver carcinogenesis: Direct measurement of communication in vivo. Carcinogenesis 12:1701-1706.
42. H. Yamasaki (1990). Gap junctional intercellular communication and carcinogenesis. Carcinogenesis 11:1051-1058.
43. S. A. Garber, M. J. Fernstrom, G. D. Stoner, and R. J. Ruch (1997). Altered gap junctional intercellular communication in neoplastic rat esophageal epithelial cells. Carcinogenesis 18:1149-1153.
44. C. Tomasetto, M. J. Neveu, J. Daley, P. K. Horan, and R. Sager (1993). Specificity of gap junction communication among human mammary cells and connexin transfectants in culture. J. Cell Biol. 122:157-167.
45. S. W. Lee, C. Tomasetto, D. Paul, K. Keyomarsi, and R. Sager (1992). Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J. Cell Biol. 118:1213-1221.
46. K. K. Hirschi, C. E. Xu, T. Tsukamoto, and R. Sager (1996). Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ. 7:861-870.
47. K. K. Wilgenbus, C. J. Kirkpatrick, R. Knuechel, K. Willecke, and O. Traub (1992). Expression of Cx26, Cx32 and Cx43 gap junction proteins in normal and neoplastic human tissues. Int. J. Cancer 51: 22-529.
48. G. P. Robertson, A. B. Coleman, and T. G. Lugo (1996). Mechanisms of human melanoma cell growth and tumor suppression by chromosome 6. Cancer Res. 56:1635-1641.
49. M. P. Piechocki, R. D. Burk, and R. J. Ruch (1999). Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells. Carcinogenesis 20:401-406.
50. L. S. Musil, A. C. Le, J. K. VanSlyke, and L. M. Roberts (2000). Regulation of connexin degradation as a mechanism to increase gap junction assembly and function. J. Biol. Chem. 275: 5207-25215.
51. B. Rose, P. P. Mehta, and W. R. Loewenstein (1993). Gap-junction protein gene suppresses tumorigenicity. Carcinogenesis 14: 073-1075.
52. T. J. King, L. H. Fukushima, T. A. Donlon, A. D. Hieber, K. A. Shimabukuro, and J. S. Bertram (2000). Correlation between growth control, neoplastic potential and endogenous connexin43 expression in HeLa cell lines: Implications for tumor progression. Carcinogenesis 21:311-315.
53. D. Zhu, G. M. Kidder, S. Caveney, and C. C. Naus (1992). Growth retardation in glioma cells cocultured with cells over-expressing a gap junction protein. Proc. Natl. Acad. Sci. USA. 89:10218-10221.
54. R. P. Huang, Y. Fan, M. Z. Hossain, A. Peng, Z. L. Zeng, and A. L. Boynton (1998). Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res. 58: 089-5096.
55. V. A. Krutovskikh, S. M. Troyanovsky, C. Piccoli, H. Tsuda, M. Asamoto, and H. Yamasaki (2000). Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene 19:505-513.
56. D. L. Dankort and W. J. Muller (2000). Signal transduction in mammary tumorigenesis: A transgenic perspective. Oncogene 19: 038-1044.
57. R. Heimann and S. Hellman (2000). Individual characterisation of the metastatic capacity of human breast carcinoma. Eur. J. Cancer 36:1631-1639.
58. J. Yokota (2000). Tumor progression and metastasis. Carcinogenesis 21:497-503.
59. J. Russo and I. H. Russo (2001). The pathway of neoplastic transformation of human breast epithelial cells. Radiat. Res. 155:151-154.
60. R. Engers and H. E. Gabbert (2000). Mechanisms of tumor metastasis: Cell biological aspects and clinical implications. J. Cancer Res. Clin. Oncol. 126:682-692.
61. M. J. Seraj, R. S. Samant, M. F. Verderame, and D. R. Welch (2000). Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 11q13. Cancer Res. 60:2764-2769.
62. A. Navolotski, A. Rumjnzev, H. Lu, D. Proft, P. Bartholmes, and K. S. Zanker (1997). Migration and gap junctional intercellular communication determine the metastatic phenotype of human tumor cell lines. Cancer Lett. 118:181-187.
63. G. L. Nicolson, K. M. Dulski, and J. E. Trosko (1988). Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 85:473-476.
64. J. Hamada, N. Takeichi, and H. Kobayashi (1988). Metastatic capacity and intercellular communication between normal cells and metastatic cell clones derived from a rat mammary carcinoma. Cancer Res. 48:5129-5132.
65. J. Hamada, N. Takeichi, J. Ren, and H. Kobayashi (1991). Junctional communication of highly and weakly metastatic variant clones from a rat mammary carcinoma in primary and metastatic sites. Invasion Metastasis 11:149-157.
66. J. Ren, J. Hamada, N. Takeichi, S. Fujikawa, and H. Kobayashi (1990). Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary carcinoma. Cancer Res. 50:358-362.
67. M. M. Saunders, M. J. Seraj, Z. Li, Z. Zhou, C. R. Winter, D. R. Welch, and H. J. Donahue (2001). Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res. 61:1765-1767.
68. A. Shoji, Y. Sakamoto, T. Tsuchiya, K. Moriyama, T. Kaneko, T. Okubo, M. Umeda, and K. Miyazaki (1997). Inhibition of tumor promoter activity toward mouse fibroblasts and their in vitro transformation by tissue inhibitor of metalloproteinases-1 (TIMP-1). Carcinogenesis 18: 093-2100.
69. W. H. Fletcher, W. W. Shin, T. A. Ishida, D. L. Haviland, and C. F. Ware (1987). Resistance to the cytolytic action of lymphotoxin and tumor necrosis factor coincides with the presence of gap junctions uniting target cells. J. Immunol. 139:956-962.
70. M. E. el Sabban and B. U. Pauli (1994). Adhesion-mediated gap junctional communication between lung-metastatatic cancer cells and endothelium. Invasion Metastasis 14:164-176.
71. A. Ito, F. Katoh, T. R. Kataoka, M. Okada, N. Tsubota, H. Asada, K. Yoshikawa, S. Maeda, Y. Kitamura, H. Yamasaki, and H. Nojima (2000). A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J. Clin. Invest. 105:1189-1197.
72. Y. Kamibayashi, Y. Oyamada, M. Mori, and M. Oyamada (1995). Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis 16:1287-1297.